West Pharmaceutical Services (WST) Risk Factor Changes

The manufacturing of some of our products has involved, and may continue to involve, the use, transportation, storage, and disposal of hazardous or toxic materials and is subject to various environmental protection an…

Many of our customers are subject to the same or related emerging legislation or regulations and, as a result, may request that changes be made to our products, procedures or facilities, as well as other aspects of ou…

We believe it is likely that the scientific and political attention to issues concerning the extent and causes of climate change will continue, with new and more restrictive legislation or regulations and focus on cli…

Our future success depends, in large part, on our ability to attract and retain key employees, including our executive officers and individuals in technical, marketing, sales, and research positions.

We may not succeed in completing divestitures, acquisitions or other strategic transactions, all of which could have an adverse effect on our business and results of operations.

The medical technology industry is very competitive and customer requests and/or new products in the marketplace could cause a reduction in demand.

Our business depends to a substantial extent on customers’ continued sales and development of products that are delivered by injection, such as GLP-1s.

A significant portion of our net sales and earnings are generated internationally.

Global economic conditions, including inflation and supply chain disruptions, could adversely affect our operations.

As of the filing of this Form 10-K, there were no unresolved comments from the Staff of the SEC.

Effective internal controls are necessary for us to provide reliable and accurate financial statements and to effectively prevent fraud.

If we fail to maintain an effective system of internal controls, we may not be able to accurately report our financial results, which could lead to a loss of investor confidence in our financial statements and have an…

We derive a substantial portion of our revenue from a limited number of customers.

The concentration of our customer base could adversely affect our financial condition and operating results.

With respect to divestitures or dispositions, we continually assess the strategic fit of our existing businesses and products and may divest or otherwise dispose of businesses or products for strategic, financial or o…

In the normal course of business, we engage in discussions with third parties relating to possible divestitures, acquisitions and other strategic transactions.